Rationale for combining tyrosine kinase inhibitors and T cell redirecting antibodies to mitigate cytokine release syndrome (CRS)

.

Source: Expert Opinion on Biological Therapy - January 30, 2023 Category: Drugs & Pharmacology Authors: Gabrielle Leclercq-cohen Marina Bacac Christian Klein Source Type: research